回复：乳腺癌分期：18F-FDG PET/CT应提供给哪些女性？ - Suppr

Suppr

超能文献

Reply: Breast Cancer Staging: To Which Women Should 18F-FDG PET/CT Be Offered?

作者信息

Ulaner Gary A, Riedl Christopher C

机构信息

Memorial Sloan Kettering Cancer Center 1275 York Ave., Box 77 New York, NY 10065 E-mail:

出版信息

J Nucl Med. 2015 Aug;56(8):1293-4. doi: 10.2967/jnumed.115.161042. Epub 2015 Jun 25.

DOI:10.2967/jnumed.115.161042

PMID:26112021

Abstract

摘要

相似文献

Reply: Breast Cancer Staging: To Which Women Should 18F-FDG PET/CT Be Offered?

J Nucl Med. 2015 Aug;56(8):1293-4. doi: 10.2967/jnumed.115.161042. Epub 2015 Jun 25.

Breast Cancer Staging: To Which Women Should 18F-FDG PET/CT Be Offered?

J Nucl Med. 2015 Aug;56(8):1293. doi: 10.2967/jnumed.115.160945. Epub 2015 Jun 4.

¹⁸F-FDG PET/CT for Staging and Restaging of Breast Cancer.

J Nucl Med. 2016 Feb;57 Suppl 1:17S-26S. doi: 10.2967/jnumed.115.157859.

Role of 2-[18F] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in the post-therapy surveillance of breast cancer.

PLoS One. 2014 Dec 17;9(12):e115127. doi: 10.1371/journal.pone.0115127. eCollection 2014.

Prone 18F-FDG PET/CT changes diagnostic and surgical intervention in a breast cancer patient: some considerations about PET/CT imaging acquisition protocol.

Clin Imaging. 2015 May-Jun;39(3):506-9. doi: 10.1016/j.clinimag.2014.11.005. Epub 2014 Nov 18.

Advantages and limitations of FDG PET in the follow-up of breast cancer.

Eur J Nucl Med Mol Imaging. 2004 Jun;31 Suppl 1:S125-34. doi: 10.1007/s00259-004-1535-8. Epub 2004 Apr 15.

PET/CT supports breast cancer diagnosis and treatment.

Breast Cancer. 2008;15(3):224-30. doi: 10.1007/s12282-008-0051-2.

18F-FDG PET in detecting primary breast cancer.

J Nucl Med. 2007 Oct;48(10):1751; author reply 1752. doi: 10.2967/jnumed.107.043265.

Breast cancer staging in a single session: whole-body PET/CT mammography.

J Nucl Med. 2008 Aug;49(8):1215-22. doi: 10.2967/jnumed.108.052050. Epub 2008 Jul 16.

Evaluation of ¹⁸F-FDG PET/MRI, ¹⁸F-FDG PET/CT, MRI, and CT in whole-body staging of recurrent breast cancer.

Eur J Radiol. 2016 Feb;85(2):459-65. doi: 10.1016/j.ejrad.2015.12.010. Epub 2015 Dec 19.

引用本文的文献

F-FDG-PET/CT for systemic staging of patients with newly diagnosed ER-positive and HER2-positive breast cancer.

Eur J Nucl Med Mol Imaging. 2017 Aug;44(9):1420-1427. doi: 10.1007/s00259-017-3709-1. Epub 2017 Apr 29.

(18)F-FDG-PET/CT for systemic staging of newly diagnosed triple-negative breast cancer.

Eur J Nucl Med Mol Imaging. 2016 Oct;43(11):1937-44. doi: 10.1007/s00259-016-3402-9. Epub 2016 Apr 30.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Reply: Breast Cancer Staging: To Which Women Should 18F-FDG PET/CT Be Offered?

J Nucl Med. 2015 Aug;56(8):1293-4. doi: 10.2967/jnumed.115.161042. Epub 2015 Jun 25.

Breast Cancer Staging: To Which Women Should 18F-FDG PET/CT Be Offered?

J Nucl Med. 2015 Aug;56(8):1293. doi: 10.2967/jnumed.115.160945. Epub 2015 Jun 4.

¹⁸F-FDG PET/CT for Staging and Restaging of Breast Cancer.

J Nucl Med. 2016 Feb;57 Suppl 1:17S-26S. doi: 10.2967/jnumed.115.157859.

Role of 2-[18F] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in the post-therapy surveillance of breast cancer.

PLoS One. 2014 Dec 17;9(12):e115127. doi: 10.1371/journal.pone.0115127. eCollection 2014.

Prone 18F-FDG PET/CT changes diagnostic and surgical intervention in a breast cancer patient: some considerations about PET/CT imaging acquisition protocol.

Clin Imaging. 2015 May-Jun;39(3):506-9. doi: 10.1016/j.clinimag.2014.11.005. Epub 2014 Nov 18.

Advantages and limitations of FDG PET in the follow-up of breast cancer.

Eur J Nucl Med Mol Imaging. 2004 Jun;31 Suppl 1:S125-34. doi: 10.1007/s00259-004-1535-8. Epub 2004 Apr 15.

PET/CT supports breast cancer diagnosis and treatment.

Breast Cancer. 2008;15(3):224-30. doi: 10.1007/s12282-008-0051-2.

18F-FDG PET in detecting primary breast cancer.

J Nucl Med. 2007 Oct;48(10):1751; author reply 1752. doi: 10.2967/jnumed.107.043265.

Breast cancer staging in a single session: whole-body PET/CT mammography.

J Nucl Med. 2008 Aug;49(8):1215-22. doi: 10.2967/jnumed.108.052050. Epub 2008 Jul 16.

Evaluation of ¹⁸F-FDG PET/MRI, ¹⁸F-FDG PET/CT, MRI, and CT in whole-body staging of recurrent breast cancer.

Eur J Radiol. 2016 Feb;85(2):459-65. doi: 10.1016/j.ejrad.2015.12.010. Epub 2015 Dec 19.

引用本文的文献

F-FDG-PET/CT for systemic staging of patients with newly diagnosed ER-positive and HER2-positive breast cancer.

Eur J Nucl Med Mol Imaging. 2017 Aug;44(9):1420-1427. doi: 10.1007/s00259-017-3709-1. Epub 2017 Apr 29.

(18)F-FDG-PET/CT for systemic staging of newly diagnosed triple-negative breast cancer.

Eur J Nucl Med Mol Imaging. 2016 Oct;43(11):1937-44. doi: 10.1007/s00259-016-3402-9. Epub 2016 Apr 30.